We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LLC:ASXLendlease Group Analysis

Data as of 2026-03-15 - not real-time

A$3.51

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Lendlease (LLC.AX) is trading at AUD 3.51, just above the computed support of 3.48 and well below its 20‑day SMA of 4.06, indicating a bearish price environment. The 14‑day RSI sits at 14.4, signaling extreme oversold conditions that could trigger a short‑term bounce. MACD remains bearish with the line under the signal, reinforcing the downtrend. Volume is increasing, suggesting heightened trader interest despite the weakness. The forward P/E of 5.95 is dramatically lower than the industry average of 32.5, and the price‑to‑book of 0.43 places the stock deep in value territory. A dividend yield of 6.6% and a payout ratio under 50% make the income profile attractive.
However, revenue has contracted ‑37% year‑on‑year and operating margins are negative, leading to a trailing EPS of ‑0.21 and a sizable net debt of AUD 4.2 billion. Free cash flow is negative and the debt‑to‑equity ratio exceeds 75%, raising concerns about cash‑flow sustainability. Recent headlines note a “surprise loss” that pushed the share price lower, adding to short‑term downside pressure. The company’s beta of 0.38 and a 30‑day volatility of 31.5% point to modest market correlation but high price swings. With a market‑cap of AUD 2.4 billion and moderate average volumes, liquidity is adequate but not abundant. Given the undervalued metrics, strong dividend, but weak earnings and high leverage, the stock sits at a crossroads between value appeal and financial risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Surprise loss and negative earnings
  • Bearish technical indicators (below SMA, low RSI)
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount (low forward P/E, low P/B)
  • Attractive dividend yield
  • Analyst price targets indicating upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Heavy debt load and negative cash flow
  • Diversified global asset base
  • Potential for dividend sustainability concerns

Key Metrics & Analysis

Financial Health

Revenue Growth-37.30%
Profit Margin-2.33%
P/E Ratio6.0
ROE-2.66%
ROA-0.10%
Debt/Equity75.51
P/B Ratio0.4
Op. Cash FlowA$-833000000
Free Cash FlowA$-811124992
Industry P/E32.5

Technical Analysis

TrendBearish
RSI14.4
SupportA$3.48
ResistanceA$4.72
MA 20A$4.06
MA 50A$4.56
MA 200A$5.19
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target PriceA$5.48
Upside/Downside56.21%
GradeUndervalued
TypeValue
Dividend Yield6.60%

Risk Assessment

Beta0.38
Volatility31.56%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.